HPV vaccine approved for cervical cancer prevention

Girls, women in China will have access to drug in wide use globally

The first vaccine for the human papilloma virus has been licensed for use on the Chinese mainland.

Approval by the China Food and Drug Administration means that girls and young women in China will be able to access a preventive vaccine against the virus, which can cause cervical cancer.